European Commission grants approval for Novartis's Signifor to treat acromegaly

Swiss drug-maker Novartis has received approval from European Commission for its Signifor (pasireotide) intramuscular injection to treat adult patients suffering from acromegaly.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news